Robotic device appears useful for surgical removal of cancer involving t...(plications occurred in five of the 27 pa...),Health

Date:12/17/2007

plications occurred in five of the 27 patients (19 percent), most were resolved without significant consequences. The early complication rate is comparable to the rates reported for the alternative therapies of non-robotic transoral surgery, open surgical resection and concurrent chemoradiation treatments, the authors write. Complicationsincluding death, pneumonia or fistula (an opening or passage in the skin or organs)that are usually reported during these other types of procedures did not occur in the TORS patients.

Radical tonsillectomy using TORS is a new technique that offers excellent access for resection of carcinomas of the tonsil with acceptable acute morbidity, or complications, they conclude. Future reports will focus on long-term oncologic and functional outcomes.

'/>"/>

Contact: Marc Kaplan 215-662-2560 JAMA and Archives Journals Source:Eurekalert

0 GOOD

Page: 1 2
Related medicine news :

1. St. Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders
2. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
3. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
4. Robotics lab helps stroke patients with recovery
5. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
6. MSU engineering team designs innovative medical device
7. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
8. Implantable device designed to detect, stop seizures under study at MCG
9. Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers
10. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
11. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)